E-LIB Suche - Ergebnisse für: Bourliere, Marc

1

Real‐world economic burden of hepatitis C and impact of dir..:

Lam, Laurent ; Carrieri, Patrizia ; Hejblum, Gilles...
Liver International. 44 (2024) 5 - p. 1233-1242 , 2024

Link: https://doi.org/10.1111/..

2

OS-034 Safety and efficacy of REP 2139-Mg in hepatitis D pa..:

Stern, Christiane ; Bourliere, Marc ; Loustaud-Ratti, Veronique...
Journal of Hepatology. 80 (2024) - p. S28 , 2024

Link: https://doi.org/10.1016/..

3

WED-455 Sex disparities in initiation of direct-acting anti..:

Ramier, Clémence ; Brouard, Cécile ; Beo, Vincent Di...
Journal of Hepatology. 80 (2024) - p. S670-S671 , 2024

Link: https://doi.org/10.1016/..

4

JNJ-73763989 and bersacapavir treatment in nucleos(t)ide an..:

Agarwal, Kosh ; Buti, Maria ; van Bömmel, Florian...
Journal of Hepatology. , 2024

Link: https://doi.org/10.1016/..

5

FRI-371 Undetectable HDV RNA at 24 weeks of treatment with ..:

Zoulim, Fabien ; Chulanov, Vladimir ; Lampertico, Pietro...
Journal of Hepatology. 80 (2024) - p. S764 , 2024

Link: https://doi.org/10.1016/..

6

French guidelines on TIPS: Indications and modalities:

Larrue, Hélène ; Allaire, Manon ; Weil‐Verhoeven, Delphine...
Liver International. , 2024

Link: https://doi.org/10.1111/..

7

Sa1638 SAFETY AND EFFICACY OF REP 2139-MG AGAINST HBV / HDV..:

Stern, Christiane ; Bourliere, Marc ; Loustaud-Ratti, Veronique...
Gastroenterology. 166 (2024) 5 - p. S-1608-S-1609 , 2024

Link: https://doi.org/10.1016/..

8

GS-002 48-week off-therapy efficacy and safety of bulevirti..:

Asselah, Tarik ; Chulanov, Vladimir ; Lampertico, Pietro...
Journal of Hepatology. 80 (2024) - p. S1-S2 , 2024

Link: https://doi.org/10.1016/..

9

THU-466 Treatment with Atezolizumab-Bevacizumab for hepatoc..:

Allaire, Manon ; Hajer, Ben Khadhra ; Amaddeo, Giuliana...
Journal of Hepatology. 80 (2024) - p. S444 , 2024

Link: https://doi.org/10.1016/..

10

WED-395 Undetectable hepatitis delta virus RNA at the end o..:

Zoulim, Fabien ; Asselah, Tarik ; Chulanov, Vladimir...
Journal of Hepatology. 80 (2024) - p. S796 , 2024

Link: https://doi.org/10.1016/..

11

OS-060 Hepatocellular carcinoma development despite histolo..:

Nahon, Pierre ; lusivka-Nzinga, Clovis ; Merle, Philippe...
Journal of Hepatology. 80 (2024) - p. S41-S42 , 2024

Link: https://doi.org/10.1016/..

12

Management of chronic HBV‐HDV patients chronic HBV‐HDV infe..:

Buti, María ; Gonzalez, Alexia ; Riveiro‐Barciela, Mar.
United European Gastroenterology Journal. 12 (2023) 2 - p. 210-218 , 2023

Link: https://doi.org/10.1002/..

13

Integrating genetic variants into clinical models for hepat..:

Nahon, Pierre ; Bamba-Funck, Jessica ; Layese, Richard...
Journal of Hepatology. 78 (2023) 3 - p. 584-595 , 2023

Link: https://doi.org/10.1016/..

14

Safety and efficacy of REP 2139-Mg in association with TDF ..:

Stern, Christiane ; De-Freitas, Cecilia ; Bazinet, Michel...
Journal of Hepatology. 78 (2023) - p. S1160 , 2023

Link: https://doi.org/10.1016/..

15

550 SAFETY AND EFFICACY OF REP 2139-MG IN ASSOCIATION WITH ..:

Stern, Christiane ; De FREITAS, Cecilia ; Bazinet, Michel...
Gastroenterology. 164 (2023) 6 - p. S-1252 , 2023

Link: https://doi.org/10.1016/..